SCYX Q3 2017 Earnings — SCYNEXIS, Inc. Revenue & Financial Results | Market Cap Arena

SCYXSCYNEXIS, Inc.

$37M

Q3 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$64,000+0.0% YoY

Gross Profit

$64,000100.0% margin

Operating Income

-$6M-9998.4% margin

Net Income

-$8M-13126.6% margin

EPS (Diluted)

$-3.10

QoQ Revenue Growth

+0.0%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$408,000

Balance Sheet

Total Assets

$50M

Total Liabilities

$22M

Stockholders' Equity

$27M

Cash & Equivalents

$9M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$64,000	$64,000	+0.0%
Gross Profit	$64,000	$64,000	+0.0%
Operating Income	-$6M	-$7M	+4.6%
Net Income	-$8M	-$11M	+25.2%